SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013348
Filing Date
2022-05-13
Accepted
2022-05-13 16:33:00
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 813936
2 ex31.htm EX-31 37071
3 ex32.htm EX-32 8749
  Complete submission text file 0001493152-22-013348.txt   5403078

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE age-20220331.xsd EX-101.SCH 41736
5 XBRL CALCULATION FILE age-20220331_cal.xml EX-101.CAL 63499
6 XBRL DEFINITION FILE age-20220331_def.xml EX-101.DEF 182364
7 XBRL LABEL FILE age-20220331_lab.xml EX-101.LAB 353316
8 XBRL PRESENTATION FILE age-20220331_pre.xml EX-101.PRE 291637
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 888223
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 22923343
SIC: 2834 Pharmaceutical Preparations